<DOC>
	<DOC>NCT00993720</DOC>
	<brief_summary>The aim of the study is to investigate the effect of Victoza (a GLP-1 receptor agonist)on insulin-dose, risk of hypoglycemia and gastric emptying rate during hypoglycemia in patients with type 1 diabetes.</brief_summary>
	<brief_title>Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>age 1850y, BMI 1827, caucasian origin, type 1 diabetes diagnosed between age 5 and age 40, no known diabetes complications or cardiovascular diseases, no medication known to influence glucose homeostasis, no pregnancy diabetes complications, autonomous nerve dysfunction, anaemia, HbA1c &lt; 8.5% at screening, estimated by the investigator to be incapable of completing the trial.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>patients with type 1 diabetes mellitus</keyword>
</DOC>